ST
BIIB icon

Sentinel Trust’s Biogen BIIB Stock Holding History

Sentinel Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,830
Closed -$2.06M – 48
2018
Q4 		$2.06M Buy
6,830
+560
+9% +$179K 0.63% 33
2018
Q3 		$2.21M Sell
6,270
-6,920
-52% -$2.38M 0.48% 57
2018
Q2 		$3.83M Sell
13,190
-3,220
-20% -$905K 0.86% 35
2018
Q1 		$4.49M Buy
16,410
+530
+3% +$165K 0.95% 31
2017
Q4 		$5.06M Buy
15,880
+9,895
+165% +$3.17M 1.05% 26
2017
Q3 		$1.87M Buy
+5,985
New +$1.77M 0.31% 75

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sentinel Trust's BIIB Position: Q1 2019 in Review

Sentinel Trust sold out of Biogen (BIIB) in Q1 2019, closing a stake of 6,830 shares — an estimated $2.06M sold.

Sentinel Trust first reported a position in BIIB in Q3 2017 and held it in 6 quarters. The position peaked at $5.06M in Q4 2017. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Sentinel Trust reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Sentinel Trust sold 6,830 Biogen shares in Q1 2019, an estimated $2.06M.
  • Sentinel Trust first reported a position in Biogen in Q3 2017 and held it in 6 quarters.
  • Sentinel Trust's Biogen position peaked at $5.06M in Q4 2017.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Sentinel Trust's 13F filing for Q1 2019, filed 15 May 2019.